Cardiovascular Diseases Research in Indiana
Cardiovascular Diseases Research (93.837) awarded $197 million to recipients in Indiana in 135 grants from fiscal 2021 to 2025, 1.3% of the program's national total. Trustees of Indiana University received the most, $160 million.
- Awarded in Indiana$197 million
- Awards135
- Share of the program1.3%
- Rank among states22nd of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 63 | $37.3 million |
| FY 2022 | 74 | $41.5 million |
| FY 2023 | 77 | $41.2 million |
| FY 2024 | 74 | $39.6 million |
| FY 2025 | 67 | $37.7 million |
Recipients in Indiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Indiana University | Colleges and universities | 108 | $160 million |
| New England Research Institutes Inc | Small businesses | 3 | $16.3 million |
| Purdue University | Colleges and universities | 7 | $9.7 million |
| Trustees of Indiana University | Colleges and universities | 9 | $6.0 million |
| University of Notre Dame Du Lac | Colleges and universities | 5 | $2.4 million |
| Vasculonics Inc | Small businesses | 1 | $2.4 million |
| Ball State University | Colleges and universities | 1 | $428,961 |
| Teichos Laboratories, LLC | Small businesses | 1 | $259,613 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Indiana?
$197 million from fiscal 2021 to 2025, across 135 awards. Indiana ranks 22nd of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Indiana?
The largest recipient is Trustees of Indiana University, with $160 million in 108 awards. Next are New England Research Institutes Inc and Purdue University.
Can organizations in Indiana apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Indiana
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program